These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 15537486

  • 1. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ, Safani M.
    Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
    [Abstract] [Full Text] [Related]

  • 2. Management of peripheral arterial disease.
    Aronow WS.
    Cardiol Rev; 2005 Nov; 13(2):61-8. PubMed ID: 15705252
    [Abstract] [Full Text] [Related]

  • 3. Peripheral arterial disease: a review of disease awareness and management.
    Watson K, Watson BD, Pater KS.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [Abstract] [Full Text] [Related]

  • 4. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [Abstract] [Full Text] [Related]

  • 5. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
    Boissel JP.
    Arch Mal Coeur Vaiss; 1991 Nov 01; 84(11 Suppl):1721-4. PubMed ID: 1837446
    [Abstract] [Full Text] [Related]

  • 6. Peripheral arterial disease. A systemic disease extending beyond the affected extremity.
    Federman DG, Bravata DM, Kirsner RS.
    Geriatrics; 2004 Apr 01; 59(4):26, 29-30, 32 passim. PubMed ID: 15086071
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S, Diehm C, Darius H, Haberl R, Allenberg JR, Pittrow D, Schuster A, von Stritzky B, Tepohl G, Trampisch HJ.
    Exp Clin Endocrinol Diabetes; 2004 Nov 01; 112(10):566-73. PubMed ID: 15578331
    [Abstract] [Full Text] [Related]

  • 8. Consensus on anti-platelet therapy in peripheral arterial disease: saving lives and limbs.
    Donnelly R, Collinson DJ.
    Platelets; 2003 Nov 01; 14(7-8):403-6. PubMed ID: 14713508
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR.
    J Vasc Surg; 2002 Dec 01; 36(6):1283-91. PubMed ID: 12469066
    [Abstract] [Full Text] [Related]

  • 10. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F, Balsano F.
    Clin Trials Metaanal; 1994 Apr 01; 29(1):81-7. PubMed ID: 10150187
    [Abstract] [Full Text] [Related]

  • 11. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
    Ferreira AC, Macedo FY.
    Ann Med; 2010 Mar 01; 42(2):139-50. PubMed ID: 20156042
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar 01; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 13. Peripheral arterial disease in women.
    Aronow WS.
    Maturitas; 2009 Dec 20; 64(4):204-11. PubMed ID: 19853389
    [Abstract] [Full Text] [Related]

  • 14. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA, CHARISMA Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1982-8. PubMed ID: 17498584
    [Abstract] [Full Text] [Related]

  • 15. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
    Black C, Paterson KR.
    Adverse Drug React Toxicol Rev; 2001 Dec 15; 20(4):277-303. PubMed ID: 11770173
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk reduction with clopidogrel in the management of peripheral arterial disease.
    Nayak KR, Cavendish JJ.
    Vasc Health Risk Manag; 2007 Dec 15; 3(3):289-97. PubMed ID: 17703636
    [Abstract] [Full Text] [Related]

  • 20. Peripheral arterial disease: identification and implications.
    Mohler ER.
    Arch Intern Med; 2003 Oct 27; 163(19):2306-14. PubMed ID: 14581250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.